Global Tourette Syndrome Market Growth Propelled by Continual Advancements in TS Therapeutics

April 24, 2023 | Healthcare

According to the latest report by IMARC Group, titled “Tourette Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033”, the global tourette syndrome market size is witnessing steady growth. Tourette Syndrome (TS) refers to a neurological disorder that is characterized by repetitive, involuntary movements and vocalizations called tics. Movement tics include blinking, facial grimacing, shoulder shrugging, and jerking of limbs, while vocal tics involve grunting, throat clearing, and repeated phrases. It is common for TS symptoms to begin in childhood, but symptoms can vary in severity throughout life, as TS symptoms must be present for at least a year before age 18 to be diagnosed. The symptoms of TS can negatively affect an individual's day-to-day functioning, including concentration, communication, and motor control as well as co-occurring conditions, such as attention-deficit/hyperactivity disorder (ADHD) and obsessive-compulsive disorder (OCD). However, the usage of medication, therapy, and support from family and doctors may help individuals with TS manage their symptoms. 


Global Tourette Syndrome Market Trends:

The global market is majorly driven by the increasing prevalence of undiagnosed Tourette syndrome in infants. In line with this, the rising focus on early diagnosis and preventive care practices are also acting as a significant growth-inducing factor for the market. Moreover, continual technological advancements in TS therapeutics, such as deep brain stimulation and transcranial magnetic stimulation therapies, are providing an impetus to the market. Besides this, favorable government initiatives supporting better healthcare infrastructure, along with various awareness programs for patients with TS, is also propelling the market growth. Additionally, the increasing awareness of the impact of Tourette syndrome on patients and their families is propelling the demand for more effective drugs and therapies. The market is further fueled by the rising number of clinical trials and the emergence of new pipeline drugs with minimal side effects. Furthermore, growing investments and funding for research into the root causes and treatment options of TS, along with the development of new medications and therapies, are creating a positive outlook for the market. Apart from this, the shifting preference toward pharmacological treatments from non-pharmacological therapies to facilitate better controlling of TS symptoms is impacting the market positively. 


Market Summary:

  • Based on the marketed products, the market has been segmented into in-market drugs (Abilify (Aripiprazole) - Bristol-Myers Squibb/Otsuka Pharmaceutical, Haloperidol, and Pimozide) and late-stage pipeline drugs (Deutetrabenazine - Teva Pharmaceutical, Ecopipam - Emalex Biosciences, SCI110 - SciSparc, and Valbenazine - Neurocrine Biosciences).
  • On the geographical front, the market has been segregated into the United States, Germany, France, the United Kingdom, Italy, Spain, and Japan.
  • This research study also offers a thorough overview of late-stage pipeline candidates and currently marketed medications for Tourette syndrome.
  • The study also offers a thorough overview of the treatment practices for Tourette syndrome, the share of specific therapies, and the performance of key market players.


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.


Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Tourette Syndrome Market Growth Propelled by Continual Advancements in TS Therapeutics
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More